Monday, March 19, 2001

BOCA RATON, Fla.--(BUSINESS WIRE)--

Mergenet Solutions, Inc. the Boca Raton based technology incubator, announced today that it has moved to acquire a majority interest in Innomed Technologies, Inc. Innomed Technologies, Inc. holds the patent to a revolutionary, FDA approved, sleep apnea device. The product itself is viewed by many as the most innovative entry in a market boasting 28 million people diagnosed with sleep apnea in this country alone.

Currently, the leading companies in the market are Respironics, Inc.(Nasdaq:RESP), and Resmed, Inc. (NYSE:RMD). Combined year 2000 sales for these companies was over a half billion dollars.

CEO of Mergenet Solutions, Inc. Shara Hernandez, feels that the majority equity acquisition in Innomed Technologies, Inc. thrusts Mergenet Solutions, Inc. into an extremely lucrative market niche.

About Mergenet Solutions, Inc.

Mergenet Solutions, Inc. is a full service technology incubator based in Boca Raton, Florida. The company also can assist private companies in their efforts to become public, as well as ancillary services, such as providing a board of directors, constructing company advisory boards, private placements, etc. The company at present has several companies under incubation and accepts applications at the company's web site (www.mergenetsolutions.com or www.gopublicnet.com ). Mergenet Solutions concentrates on technology, medical technology, and energy related companies.